For Research Purposes Only
Product image 1

PT141

From AED 700.00
1
Next-day deliveryOrder today for delivery tomorrow across the UAE
Free Shipping
Secure Checkout
Free Shipping
Secure Checkout
Share:

Shipping & Returns

Dosing Chart

Frequently Bought Together

+
+
This itemAED 700.00
RetatrutideAED 1,450.00
NAD+AED 950.00
Bundle price:AED 3,100.00

Why it matters.

01

Melanocortin peptide.

A cyclic heptapeptide agonist at central melanocortin receptors.

02

Verified by Janoshik.

Independent HPLC + MS testing. Report linked above.

03

Reference-grade.

Lyophilised powder. Sealed, labelled, batch-traceable.

How it works

Three receptors. One molecule.

01 / 03

MC4R

Melanocortin-4 receptor, the central pathway studied across bremelanotide research.

02 / 03

MC1R

Also binds the melanocortin-1 receptor, the pathway linked to melanogenesis.

03 / 03

Central signalling

Studied for CNS-mediated melanocortin signalling rather than direct vascular action.

Reference data

Inside the vial.

The molecular profile, confirmed by independent analysis.

CompoundBremelanotide (PT-141)
ClassMelanocortin receptor agonist (MC4R / MC1R)
SequenceAc-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
FormLyophilised powder
UseResearch and laboratory use only

Sources

Cited, not claimed.

Every reference below is publicly available, peer-reviewed.

011920
Obstet Gynecol · RECONNECT Ph3

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials (RECONNECT)

Kingsberg SA et al. · Obstetrics & Gynecology

021920
Obstet Gynecol · Long-term

Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder

Simon JA et al. · Obstetrics & Gynecology

030620
· Mechanism

An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist

Diamond LE et al. · Journal of Sexual Medicine